Results 61 to 70 of about 27,421 (247)

Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells [PDF]

, 2017
__Background:__ It is widely recognized that inflammation promotes breast cancer invasion and metastasis. Given the complex nature of the breast tumor inflammatory microenvironment, much remains to be understood of the molecular mechanisms that govern ...
Ashleigh Renaud, Stephanie Tsang Mui Chung, Linda Connelly, Chung, S.T.M. (Stephanie Tsang Mui), Renaud, Ashleigh, Dirk Geerts, Roseman, K. (Kim), Chung, Stephanie Tsang Mui, Roseman, Kim, Renaud, A, Renaud, A. (Ashleigh), Kim Roseman, Connelly, Linda, Chung, STM, Roseman, K, Geerts, D. (Dirk), Geerts, Dirk, Connelly, L. (Linda), Connelly, L   +18 more
core   +1 more source

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Osteoprotegerin is a new marker of cardiovascular diseases [PDF]

Терапевтический архив, 2017
Osteoprotegerin (OPG) is a glycoprotein that is a representative of the tumor necrosis factor-α receptor superfamily. Information about the possible role of OPG in the development of cardiovascular diseases has begun to appear in the literature in recent
A F Verbovoy, I A Tsanava, E V Mitroshina, L A Sharonova   +3 more
doaj   +1 more source

Therapeutic Properties and Underlying Mechanisms of Traditional Chinese Medicine in Managing Rheumatoid Arthritis: An Integrative Review of Clinical and Molecular Findings

Phytotherapy Research, EarlyView.
The translational research framework integrating TCM for RA. The figure outlines a stepwise framework for the modernization and clinical translation of TCM in RA. Part 1 highlights the inheritance and development of TCM theory, including classical medical texts, traditional herbal knowledge, and syndrome differentiation–based treatment principles. Part
Jianting Wen, Jian Liu, Lei Wan, Fanfan Wang, Yang Li   +4 more
wiley   +1 more source

Osteoprotegerin and cardiovascular disease [PDF]

, 2010
The articles of this thesis are not available in Munin: 1. Vik A, Mathiesen EB, Noto AT, Sveinbjornsson B, Brox J and Hansen JB.: 'Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans', Atherosclerosis (2007) 191(1 ...
Vik, Anders
core  

Osteoprotegerin Expressed by Osteoclasts [PDF]

Journal of Dental Research, 2014
Osteoprotegerin (OPG) is secreted by stromal and osteoblastic lineage cells and inhibits osteoclastogenesis by preventing the interaction of receptor activator of nuclear factor-κB ligand (RANKL) with receptor activator of nuclear factor-κB (RANK).
J H, Kang, H M, Ko, J S, Moon, H I, Yoo, J Y, Jung, M S, Kim, J T, Koh, W J, Kim, S H, Kim   +8 more
openaire   +2 more sources

Disrupted joint clock is associated with rhythmic expression of bone destruction factors in collagen‐induced arthritis

Rheumatology &Autoimmunity, EarlyView.
Schematic Summary of Circadian Dysregulation in Arthritic Joints. This graphical abstract illustrates the key circadian disruptions observed in the collagen‑induced arthritis (CIA) model. The diagram depicts three main findings: (1) Nocturnal elevations in pro‑inflammatory cytokines (TNF‑α, IL‑6, IL‑17, IL‑1β, MIF) and bone‑destructive factors (DKK‑1 ...
Xiaogang Zhang, Mingming Zhang, Zhiqiang Wang, Jie Bai, Xing Feng, Yajing Wang, Zhenbin Li, Dongbao Zhao   +7 more
wiley   +1 more source

Osteoprotegerin, Rank and Rank Ligand

, 2007
Osteoprotegerin, reseptör aktivatör nükleer kappa B ve reseptör aktivatör nükleer kappa B ligand’ın keşfi ve osteoklastojenezisteki rollerinin belirlenmesi kemik biyolojisinin anlaşılmasına çok önemli katkılar sağlamıştır.
Mehmetoğlu, İdris, Kurban, Sevil
core   +1 more source

Osteoprotegerin and Vascular Calcification: Clinical and Prognostic Relevance [PDF]

, 2015
Osteoprotegerin ( OPG ) is a key regulator in bone metabolism, that also has effect in vascular system. Studies suggest that osteoprotegerin is a critical arterial calcification inhibitor, and is released by endothelial cells as a protective mechanism ...
Sandra Makarovic, Robert Steiner, Makarovic, Sandra, Mihaljević, Ivan, Jasminka Milas-Ahić, Ivan Mihaljević, Makarović, Zorin, Zorin Makarović, Steiner, Robert, Milas-Ahić, Jasminka   +9 more
core   +1 more source

Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism [PDF]

European Journal of Endocrinology, 1999
The integrity of the skeleton depends upon bone remodeling, the permanent and controlled resorption of bone by osteoclasts (OC) and its subsequent replacement by bone-forming osteoblasts. An imbalance between bone resorption and bone formation results in osteoporosis (if bone resorption exceeds bone formation) or osteopetrosis (if bone formation ...
openaire   +2 more sources